Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents

Dermatology

Volumn 212, Issue SUPPL. 1, 2006, Pages 119-123

  Kariwa, Hiroaki ^a   Fujii, Nobuhiro ^b   Takashima, Ikuo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronavirus; Infection control; Povidone iodine; Severe acute respiratory syndrome

Indexed keywords

ACETONE; ALCOHOL; ANTIVIRUS AGENT; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; FORMALDEHYDE; GLUTARALDEHYDE; METHANOL; POVIDONE IODINE; TOPICAL ANTIINFECTIVE AGENT;

ANIMAL; ARTICLE; CERCOPITHECUS; DRUG EFFECT; HEAT; RADIATION EXPOSURE; SARS CORONAVIRUS; ULTRAVIOLET RADIATION; VERO CELL; VIRUS INACTIVATION;

ACETONE; ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; ETHANOL; FORMALDEHYDE; GLUTARAL; HEAT; INDICATORS AND REAGENTS; METHANOL; POVIDONE-IODINE; SARS VIRUS; ULTRAVIOLET RAYS; VERO CELLS; VIRUS INACTIVATION;

EID: 33745234131     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000089211     Document Type: Conference Paper

References (15)

1. World Health Organization: Acute respiratory syndrome, China. Wkly Epidemiol Rec 2003; 78: 41.
2. World Health Organization: Acute respiratory syndrome China, Hong Kong Special Administrative Region of China, and Viet Nam. Wkly Epidemiol Rec 2003; 78: 73-74.
3. World Health Organization: Severe acute respiratory syndrome (SARS). Wkly Epidemiol Rec 2003; 78: 181-183.
4. World Health Organization: Severe acute respiratory syndrome (SARS): over 100 days into the outbreak. Wkly Epidemiol Rec 2003; 78: 217-220.
5. Poutanen SM, Low DE, Henry B, Finkelstein S, Rose D, Green K, Tellier R, Draker R, Adachi D, Ayers M, Chan AK, Skowronski DM, Salit I, Simor AE, Slutsky AS, Doyle PW, Krajden M, Petric M, Brunham RC, McGeer AJ, National Microbiology Laboratory, Canada, Canadian Severe Acute Respiratory Syndrome Study Team: Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003; 348: 1995-2005.
6. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguiere AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Muller S, Rickerts V, Sturmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H, Doerr HW: Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348: 1967-1976.
7. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, Rollin PE, Dowell SF, Ling AE, Humphrey CD, Shieh WJ, Guarner J, Paddock CD, Rota P, Fields B, De Risi J, Yang JY, Cox N, Hughes JM, Le Duc JW, Bellini WJ, Anderson LJ, SARS Working Group: A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 348: 1953-1966.
8. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, Cheng VC, Chan KH, Tsang DN, Yung RW, Ng TK, Yuen KY, SARS Study Group: Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003; 361: 1319-1325.
9. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Penaranda S, Bankamp B, Maher K, Chen MH, Tong S, Tamin A, Lowe L, Frace M, De Risi JL, Chen Q, Wang D, Erdman DD, Peret TC, Burns C, Ksiazek TG, Rollin PE, Sanchez A, Liffick S, Holloway B, Limor J, McCaustland K, Olsen-Rasmussen M, Fouchier R, Gunther S, Osterhaus AD, Drosten C, Pallansch MA, Anderson LJ, Bellini WJ: Characterization of a novel coronavirus associated with severe acute res piratory syndrome. Science 2003; 300: 1394-1399.
10. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, Luo SW, Li PH, Zhang LJ, Guan YJ, Butt KM, Wong KL, Chan KW, Lim W, Shortridge KF, Yuen KY, Peiris JS, Poon LL: Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003; 302: 276-278.
11. World Health Organization: First data on stability and resistance of SARS coronavirus compiled by members of WHO laboratory network. Available from URL: http://www.who.int/csr/sars/survival-2003-05-04/en/index.html.
12. Reed LJ, Muench H: A simple method of estimating fifty percent endpoints. Am J Hyg 1938; 27: 493-497.
13. Yu IT, Li Y, Wong TW, Tam W, Chan AT, Lee JH, Leung DY, Ho T: Evidence of airborne transmission of the severe acute respiratory syndrome virus. N Engl J Med 2004; 350: 1731-1739.
14. Chan KH, Poon LL, Cheng VC, Guan Y, Hung IF, Kong J, Yam LY, Seto WH, Yuen KY, Peiris JS: Detection of SARS coronavirus in patients with suspected SARS. Emerg Infect Dis 2004; 10: 294-299.
15. Yam WC, Chan KH, Poon LL, Guan Y, Yuen KY, Seto WH, et al: Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus. J Clin Microbiol 2003; 41: 4521-4524.